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Abstract
Background: Cerebral palsy is the most common cause of physical disability in childhood, occurring in one in 500 
children. It is caused by a static brain lesion in the neonatal period leading to a range of activity limitations. Oral motor 
and swallowing dysfunction, poor nutritional status and poor growth are reported frequently in young children with 
cerebral palsy and may impact detrimentally on physical and cognitive development, health care utilisation, 
participation and quality of life in later childhood. The impact of modifiable factors (dietary intake and physical activity) 
on growth, nutritional status, and body composition (taking into account motor severity) in this population is poorly 
understood. This study aims to investigate the relationship between a range of factors - linear growth, body 
composition, oral motor and feeding dysfunction, dietary intake, and time spent sedentary (adjusting for motor 
severity) - and health outcomes, health care utilisation, participation and quality of life in young children with cerebral 
palsy (from corrected age of 18 months to 5 years).
Design/Methods: This prospective, longitudinal, population-based study aims to recruit a total of 240 young children 
with cerebral palsy born in Queensland, Australia between 1st September 2006 and 31st December 2009 (80 from each 
birth year). Data collection will occur at three time points for each child: 17 - 25 months corrected age, 36 ± 1 months 
and 60 ± 1 months. Outcomes to be assessed include linear growth, body weight, body composition, dietary intake, 
oral motor function and feeding ability, time spent sedentary, participation, medical resource use and quality of life.
Discussion: This protocol describes a study that will provide the first longitudinal description of the relationship 
between functional attainment and modifiable lifestyle factors (dietary intake and habitual time spent sedentary) and 
their impact on the growth, body composition and nutritional status of young children with cerebral palsy across all 
levels of functional ability.
Background
Cerebral palsy (CP) is the most common cause of physical
disability in childhood occurring in 1 in 500 children [1].
It is a group of permanent disorders of movement and
posture, causing activity limitation, that are attributed to
non-progressive disturbances that occurred in the devel-
oping foetal or infant brain [2]. Damage to the structure
of the brain is static and permanent; however, the conse-
quent symptoms are variable and may change over time
[2]. In addition to disordered movement or posture, chil-
dren may have a range of associated disabilities, including
intellectual disability, hearing and visual deficits, nutri-
tion, feeding and swallowing problems, respiratory infec-
tions and epilepsy [1]. Cerebral palsy has substantial life
long effects on daily function and quality of life (QOL) for
children and their families with an estimated economic
cost of over AUD $115,000 per person per annum [3].
Growth and nutritional status of children with CP
Poor growth and nutritional status are commonly
reported in children with CP [4,5]. Conversely, there is
evidence to suggest that certain children with CP are at
risk of obesity, particularly those with marked spasticity
and who are relatively inactive [6]. Poor growth is fre-
quently considered a 'normal', untreatable side-effect of
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CP, however, the impact of poor growth on health, partic-
ipation and QOL is an area that requires further investi-
ga tion [7]. M ost st udies ha ve concentra t ed on sever e ly
impaired children and are frequently flawed by a lack of
valid and repeatable methods for assessing linear growth
and body composition in this population [8].
The largest study to date into the growth parameters of
children and adolescents with CP was based on retro-
spective data relating to height and weight obtained from
the patient records of 24,920 children and adolescents
aged 2 - 20 years. The 10th, 50th and 90th percentile curves
for body weight, height and body mass index (BMI) were
developed from over 141,900 measurements of weight
and height [8]. This study confirmed that children with
moderate to severe motor impairment are growth
impaired. Trends for lower weight and height for age
were apparent for the lower functioning groups and devi-
ated further from those of the general population with
increasing functional impairment. The largest differences
in weight and height were seen in those with the most
severe motor impairment. Interestingly, in the lowest
functioning groups (groups 4 and 5), the presence of a
feeding tube was associated with greater weight and
height (group 5), in comparison to children in group 4
who did not have a feeding tube. The major strengths of
this study were the large sample and the development of
growth curves stratified by gross motor skills and mode
of feeding. The most significant limitations of the study
were that the methods utilised to measure height were of
unknown validity and reliability in this population, non
validated tools were used to determine functional sever-
ity and the sample was largely cross sectional with only a
portion having repeated measures.
Importantly, the growth curves presented in this study
are purely descriptive of growth within the study popula-
tion and have not been related to health outcomes [8].
Any representative sample of children with CP will
include a large number of undernourished subjects, as
such, these population specific growth charts are not a
prescription for desirable growth in this group. This
study raises two key questions related to growth and
nutrition for children with CP: what is desirable growth
and, what is the relationship between growth, nutritional
status and health related outcomes and QOL in this pop-
ulation?
Causes of poor growth in CP
It has been hypothesised that poor growth in children
with CP may be related to nutritional factors, physical
factors or factors related to the brain lesion itself. Nutri-
tional factors include inadequate dietary intake, second-
ary to impaired oral motor and swallowing competence
and poor nutritional status and may impact directly on
growth [4,9,10]. Physical factors result in decreased
mechanical stress on bones due to immobility or lack of
weight bearing [11]. Bone growth studies have suggested
that immobilisation decreases bone formation and longi-
tudinal bone growth and increases bone resorption,
which suppresses certain growth-stimulating hormones
[11]. Factors related to the brain lesion itself may impact
on growth either directly (via a negative neurotrophic
effect on linear growth) or indirectly (via the endocrine
system) [4,10]. Growth differences between impaired and
unimpaired limbs in children with hemiplegia, support
the hypothesis that non-nutritional factors play a signifi-
cant role in reducing growth in children with CP [12].
Cross-sectional studies have identified links between
feeding ability and measures of growth and nutritional
status [13,14]. Longitudinal investigations have found
that early nutritional supplementation by gastrostomy
results in improved linear growth in children with severe
CP if commenced early in life [10,15,16]. Swallowing dif-
ficulties have been reported in up to 99% of children with
CP classified as Gross Motor Function Classification Sys-
tem (GMFCS) IV or V, the majority of which exhibit
moderate to severe (76%) or profound (15%) dysphagia
[17]. The prevalence of dysphagia in children with more
mild motor impairment (GMFCS scores I-III) is
unknown, as is the point at which oral motor dysfunction
begins impacting on dietary intake and growth. Specific
issues related to oral motor and swallowing problems in
CP include poor saliva control and drooling [18]; diffi-
culty sucking, chewing and swallowing [19-21]; and
oropharyngeal aspiration [22-24], all of which impact on
lifestyle. Poor saliva control has been associated with
health and lifestyle impacts such as poor hygiene,
reduced social acceptability of anterior drooling, reduced
social interaction and self-esteem, increased daily cares
[25-27] and aspiration of posterior drooling with associ-
ated pulmonary complications [28]. The impact of oral
motor impairment on feeding and swallowing has been
associated with reduced dietary intake leading to subop-
timal nutritional status and requirement for tube feeding
[13,14]. Other health issues related to oral motor and
swallowing problems include pulmonary complications
and pneumonia associated with oropharygneal aspiration
requiring multiple hospitalisations [28-30], and lifestyle
impacts on the child and family such as extended length
of mealtimes [31].
In a sample of 171 children with CP, Stevenson and col-
leagues [4] found that children with severe gross motor
impairment had significantly lower height Z-scores than
less impaired children and that mid arm circumference
and tricep skinfold thickness highly correlated with both
height and weight Z-scores. This study suggests that
growth is related to body composition and severity of CP.
Stallings and colleagues [9] found that disease severity
variables (oral motor function, ambulatory status, andBell et al. BMC Public Health 2010, 10:179
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gastrostomy feeding) and non-disease variables (age,
pubertal status, gender, and mid parental height)
explained approximately 70-75% of the variability in
length of 142 children with quadriplegic CP. After con-
trolling for these, body composition (upper arm muscle
area and percent body fat) explained 10-15% of the
remaining variation. The magnitude of the impact of
body composition on linear growth was similar to that of
disease severity. Importantly, body composition had a
stronger effect on the growth of younger children com-
pared to older children. Both of these studies were cross
sectional and therefore the strength of evidence is low.
The cross-sectional multi-centred study North Ameri-
can Growth in CP Project (NAGCPP) showed a signifi-
cant relationship between functional severity and
nutritional status in a group of 235 moderately to severely
impaired children (GMFCS III-V) [32,33]. These chil-
dren, aged 2-18 years, had lower fat-stores, shorter stat-
ure, and decreased muscle mass compared to typically
developing children. In addition, these studies demon-
strated an association between overall growth status and
increased health care use and impaired participation
[7,32]. The NAGCPP did not include an entire population
based sample, few children were less than 3 years and
only children with moderate to severe motor impairment
(GMFCS III-V [34]) were included. In addition, lifestyle
factors (dietary intake and time spent sedentary) were not
assessed.
Physical activity and time spent sedentary in children with 
CP
Habitual physical activity is an established determinant of
health and, in Australia, the cost of illness directly attrib-
utable to insufficient activity is AUD$377m per annum
across the entire population [35]. In children, physical
activity is required for healthy growth and development,
including building strong bones and muscles, improving
balance, and acquiring and developing motor skills [36].
The best available evidence indicates that people with
mobility impairment are among the least physically active
groups in society [37,38], and consequently children with
CP may be at risk of sub-optimal growth and develop-
ment secondary to physical inactivity. Unfortunately
studies investigating the link between time spent seden-
tary and growth and development in young children with
CP- particularly those who are unable to walk - have not
been conducted. Studies which accurately document pat-
terns of sedentary behaviour in this population and relate
the data to health outcomes are urgently needed. Such
studies require the development and evaluation of meth-
ods for assessing activity and inactivity in children who
move in a range of different ways including crawling,
cruising, rolling and bottom shuffling. Results will permit
ascertainment of the importance of inactivity prevention
and physical activity promotion strategies in the manage-
ment of children with CP, as well as the identification of
high need groups within the CP population.
Difficulties with the assessment of growth and nutritional 
status in CP
The neuromuscular complications associated with CP
make accurate anthropometric and body composition
measurements difficult and sometimes impossible in this
population. Our group, and others, have overcome this
issue by using segmental limb measures which provide
reliable, valid and clinically useful alternatives to measur-
ing height in children with CP [39-41]. For evaluation of
body composition, the use of deuterium-oxide is consid-
ered a "gold-standard-technique" due to its reliability,
accuracy and the limited assumptions required with its
use compared to other more commonly used and widely
available measures such as skinfold thicknesses; however,
its limited availability, cost and time required for analysis
result in a technique that is generally prohibitive for rou-
tine clinical use. When used in combination with pub-
lished hydration constants [42,43], deuterium-oxide can
be used to determine fat free mass and hence fat mass in
children, using the two component model of body com-
position. It is a safe, non-radioactive, naturally occurring,
isotope that has been used to measure total body water in
a wide range of groups including pregnant women,
infants and the elderly [44,45].
Current investigations into the growth, oral motor and
feeding difficulties and nutritional status of children with
CP have focused on cross sectional data at one time point
or diverse samples across a broad age range. They con-
c e n t r a t e  o n  o n l y  t h e  m o s t  s e v e r e l y  i m p a i r e d  c h i l d r e n
without use of validated measures of height, body com-
position, gross motor function and health status. Mea-
sures of feeding ability and oral motor dysfunction have
been most commonly derived from parent questionnaires
rather than the use of validated clinical tools. There have
been no longitudinal investigations into the impact of
lifestyle factors (dietary intake and time spent sedentary)
on growth, body composition, nutritional status and their
impact on health outcomes in children with CP. The pau-
city of such information reduces capacity to develop and
implement effective management strategies for this pop-
ulation.
Aims and hypotheses
This study will investigate the influence of growth, body
composition, dietary intake, oral motor and swallowing
function and time spent sedentary (adjusted for motor
severity) on health outcomes, participation and QOL in a
prospective population based study of young children
with CP (from corrected age (ca) of 18 months to 5 years).
The hypothesized interaction between these factors isBell et al. BMC Public Health 2010, 10:179
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represented graphically in the conceptual model (see fig-
ure 1).
This broad aim will be addressed by the following four
hypotheses (H):
H1
Growth status, nutritional status and growth velocity,
from 18 months of age will be related to the level of gross
motor functional attainment (GMFCS) at 5 years of age.
H2
Body composition (fat free mass and fat mass) will be
related to the level of gross motor functional attainment
at 5 years of age.
H3a
For a given GMFCS level, dietary intake, oral motor/swal-
lowing function and time spent sedentary at 3 and 5 years
of age will be significantly related to growth velocity and
body composition.
H3b
The relationship between dietary intake, oral motor/
swallowing function & time spent sedentary at 18 months
will predict growth status, nutritional status and body
composition at 5 years of age.
H4
Controlling for functional severity, children with slower
growth, suboptimal body composition (fat free mass and
fat mass), lower levels of oral motor/swallowing function
and greater time spent sedentary will have:
(i) higher health care utilisation and direct medical
costs at 3 and 5 years.
(ii) lower levels of participation in school, leisure and
community at 3 and 5 years.
(iii) poorer QOL at 5 years.
Study significance
This study will be the first longitudinal, population based
study to enable more accurate prediction of the early nat-
ural history of nutritional and growth problems in young
children with CP linked to dietary intake, time spent sed-
entary, health outcomes and resource utilization. Specifi-
cally this project will:
• Determine the nature and timing of nutritional, feed-
ing and growth abnormalities.
• Enable better prediction of the likelihood and impact
of sub-optimal dietary intake from an earlier age.
• Enable planning of nutritional treatment options at
optimal times.
• Develop and validate methods for measuring seden-
tary behaviour in young children with CP, including those
who do not walk as their primary means of locomotion.
• Highlight the relative contribution of poor dietary
intake, oral motor and feeding difficulties and sedentary
behaviour on growth and body composition taking into
account severity of disability.
• Quantify the impact of dietary intake and time spent
sedentary on medical resource use to inform service pro-
vision planning.
• Define the relationship between habitual time spent
sedentary and functional abilities to predict eventual
functional attainment.
• Define the relationship between oromotor/swallow
dysfunction and gross motor attainment.
• Quantify the impact of poor nutrition and high
amounts of time spent sedentary on participation in soci-
ety and QOL.
Figure 1 Conceptual model illustrating the hypothesized interactions of the principle factors to be investigated in the prospective, longi-
tudinal study of growth, nutrition and sedentary activity in young children with cerebral palsy.
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• Allow interpretation of data derived from clinical
methods for the assessment of body size and composition
(eg body mass index (BMI) and skin-fold thickness).
Methods/Design
This prospective, population based longitudinal study
aims to recruit a total of 240 young children with CP born
in Queensland, Australia, between 1st September 2006
and 31st December 2009. It is being conducted in con-
junction with another study: Queensland CP Child Study
of Motor Function and Brain Development (NHMRC
465128). Ethics approvals have been received from the
University of Queensland Medical Research Ethics Com-
mittee (2008002260), the Children's Health Services Dis-
trict Ethics Committee (HREC08/QRCH/112/AM01),
the CP League of Queensland (CPLQ 2008/2010 1029),
Gold Coast Health Service District Human Research Eth-
ics Committee (HREC/09/QGC/88), and the Townsville
Health Service District Human Research Ethics Commit-
tee (HREC/09/QTHS/96). Further ethics approvals are
being sought from additional paediatric and regional cen-
tres throughout Queensland.
Selection criteria
Inclusion criteria
All Queensland born children diagnosed with CP, born
between 1st September 2006 and 31st December, 2009.
We define CP as a group of permanent disorders of
movement and posture that are attributed to non-pro-
gressive disturbances that occurred in the developing foe-
tal or infant brain [2]. The characteristic signs are
spasticity, movement disorders, muscle weakness, ataxia
and rigidity [46].
Exclusion criteria
Children with a progressive or neurodegenerative lesion
will be excluded from the study.
Recruitment
Recruitment for this study commenced in April 2009 and
state-wide recruitment has been established in collabora-
tion with the Queensland CP Register, the Queensland
CP League, the Queensland Children's Health Services
District, the Queensland CP Health Service, and other
regional hospitals and health service districts throughout
Queensland. Community awareness has been generated
through paediatricians, general practitioners, allied
health professionals, child health nurses, and neonatal
follow-up clinics. These groups have been encouraged to
refer children with motor delay (not sitting at 10 months,
not standing at 12 months or walking at 24 months) for
confirmation of a diagnosis of CP. Specialist clinics have
been established within the Children's Health Services
District where suitability for the study can be confirmed.
Study entry
Eligible children will enter the study from 18 months cor-
rected age. They will be assessed for diagnostic criteria,
co-morbidities and for differential neurological assess-
ment by a Paediatric Rehabilitation Specialist and/or a
Paediatric Neurologist. All measures will be performed
on three occasions at 17 to 25 months (according to study
entry); 36 ± 1 months and 60 ± 1 months corrected age
(see Figure 2 flow chart for details). Children diagnosed
after 25 months of age may enter the study at either 30 ±
1 months or 36 ± 1 months. To ensure collection of data
at three time periods, these children will have their sec-
ond assessment conducted at 48 ± 1 months. Written
informed consent will be obtained from the parents or
legal guardians prior to the commencement of data col-
lection.
Feasibility
Children who are detected after 18 months of age will be
entered into the study at the time of diagnosis, will
receive assessment at entry and be followed up until out-
come at 5 years. According to the Queensland CP Regis-
ter there are 80-120 new children with CP born in
Queensland each year. We propose recruitment of at least
80 children each year (total 240 children from 360 poten-
tial children). High ascertainment is expected for chil-
dren with moderate to marked motor delay (GMFCS III
to IV) and this has been the case for children born pre-
term and children referred to the Queensland CP Health
Se rv i c e .  C h i l d r e n  bo r n  a t  t e r m  w i t h  m i l d  m o t o r  d e l a y
(GMFCS I and II) and predominant lower limb involve-
ment (diplegia) are typically identified through the Qld
CP Health Service and CP Orthopaedic services at the
Royal Children's and Mater Children's Hospitals.
Recruitment and data collection for this study is being
conducted in conjunction with the Queensland CP Child
Study of Motor Function and Brain Development
(NHMRC 465128). This is a population based prospec-
tive cohort study (n = 240) which aims to determine the
pathway(s) to motor outcome (gross and fine motor)
from diagnosis at 18 months to outcome at 5 years in
relation to the nature of the brain lesion (using structural
MRI). Children enter the study at 18 months of age with
assessments conducted every six months until 3 years of
age then again at 4 years and final outcomes are assessed
at 5 years.
Measurements and procedures
Gross motor function
Gross Motor Function will be determined using the
Gross Motor Function Measure (GMFM 66). The GMFM
66 has been shown to be valid and reliable and has been
Rasch analysed to enable improved scaling [47]. Gross
m o t o r  f u n c t i o n  a s s e s s m e n t  w i l l  b e  c o n d u c t e d  b y  t w oBell et al. BMC Public Health 2010, 10:179
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experienced paediatric physiotherapists whom have cri-
terion rating with the study developers (Boyd). All
GMFM assessments will be video taped to enable scoring
of the accelerometry data for validation of the Actigraph
for the identification of time spent sedentary.
Motor type
Type of CP (eg, spastic, dystonic, or hypotonic) and
motor distribution (unilateral, bilateral, number of limbs
involved) will be determined by two independent physio-
therapists at each assessment according to Sanger [46]
and the internationally accepted classification system on
the European CP Register [48]. The classification of
motor type will be recorded for both physiotherapists,
independently, at each assessment and common agree-
ment will be assessed for rating motor type at a young
age.
Functional severity
Functional severity will be determined using the interna-
tionally accepted Gross Motor Function Classification
System (GMFCS) [34] by two independent physiothera-
pists trained in performing the gross motor function
assessment. Children will be classified as being in one of
five functional categories for the age bands under two
years, two to four years and four to six years. The GMFCS
has established validity and reliability for use in young
children with CP [34,49]. Inter rater reliability for the cur-
rent study will be determined.
Anthropometry
Weight will be measured to the nearest 100 grams using
chair scales (Seca Ltd, Germany). Height or length will be
measured to the last completed millimetre with a porta-
ble stadiometer/length measuring board (Shorr Produc-
tions, LLC, Maryland, USA). Knee height and upper-arm
length will be measured with an anthropometer (Holtain
Ltd, Dyfed, UK). Intraobserver reliability has technical
errors of 0.23 cm for upper-arm length and 0.16 cm for
knee height with coefficients of variation of 1.22% and
0.56% respectively [39]. Height estimates will be pre-
dicted from knee height and upper arm length using pub-
lished validated equations [39]. Body mass index will be
calculated as weight (kg) divided by height (m) squared.
Head circumference and mid arm circumference will be
measured to the last completed millimetre using a steel
flexible measuring tape.
Duplicate measurements of tricep skin-fold thickness
and subscapular skin-fold thickness will be measured
using callipers (Holtain Ltd, Dyfed, UK) by trained inves-
tigators. By convention, all measurements will be con-
ducted on the left side of the body. This protocol is
modelled on the convention used for development of the
N a t i o n a l  C e n t r e  f o r  H e a l t h  S t a t i s t i c s  c h a r t s  [ 5 0 ] .  D a t a
from skin-fold thicknesses have been found to be useful
when assessing the nutritional status of children with CP
[14]. Reliabilities have technical errors for intraobserver
and interobserver measures of tricep skin-fold thickness
of 0.60 mm and 0.55 mm with coefficients of variation of
5.93% and 6.98% respectively [7].
Anthropometric and body composition data will be
converted to Z-scores using age and gender specific refer-
ence data for the general population [51,52]. Between-
group comparisons will be conducted across GMFCS lev-
els (I-V).
Figure 2 Flow chart of study timeline & measures from baseline (left), to completion (right). GMFCS = the Gross Motor Function classification 
System; FMS = Functional Mobility Scale: TBW = Total Body Water; PEDI = The Paediatric Evaluation of Disability Inventory; CAPE = the Children's As-
sessment of Participation and Enjoyment; CP-QOL-child = the Cerebral Palsy Quality of Life measure (child version); Dx = Confirmed diagnosis.
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Body composition
Total body water (TBW) will be measured non-invasively,
using the deuterium-dilution technique [53]. Children
will be given a dose of deuterium in the form of water
either orally or via feeding tube. In the absence of a feed-
ing tube in children with feeding difficulties, children will
be assessed to determine the most suitable technique to
enable the consumption of the isotope with minimal risk
of spillage. Any spillage that may occur will be collected
in an absorbent cloth which will be weighed before and
after dosing to accurately determine how much fluid has
been lost [54]. A single baseline urine sample will be col-
lected prior to administration of the dose to determine
natural baseline enrichments of the isotopes and a second
urine sample will be collected at approximately five hours
after dosing. Measurement of the isotopic enrichment of
a sample of body fluids at this time enables calculation of
the body water pool using standard equations [55]. Col-
lection of urine samples from children with poor or no
bladder control will involve the inclusion of an absorbent
liner in their nappy from which urine will be extracted for
analysis [54]. Analyses of the urine samples will be per-
formed using an isotope ratio mass spectrometer. Similar
procedures have been used by our group and others in
infants, children following severe traumatic brain injury
and children with mild and severe CP [53,56-58]. The
accuracy of TBW measured using the deuterium dilution
technique is excellent at approximately 1% [59], and 1 -
2% for repeated measurements [60,61]. Fat free mass will
be determined through division of TBW by age and gen-
der specific hydration factors [42].
Bioelectrical impedance analysis
Impedance (Ohm) will be measured using a Body Stat
1500MDD (Isle of Mann, UK) at 800μA and a fixed fre-
quency of 50 KHz. Children will be required to lie in a
supine position with arms and legs slightly abducted from
the trunk. The electrical current will be applied through
two non-polarizing surface electrodes placed at the dor-
sal surfaces of the hand and foot over the distal aspect of
the second and third metacarpals and metatarsals. The
voltage drop will be measured by two further electrodes
placed at the right pisiform prominence of the wrist and
between the lateral and medial malleoli of the ankle. The
proximal and distal electrodes will be a minimum of 5 cm
apart. All measurements will be taken twice, with a third
measurement taken if the difference is greater than 5
Ohm. The mean of the two closest values will be used for
analysis. Total body water will be estimated from mea-
surement of impedance and height or length using previ-
ously published equations [62-64]. The relationship
between height2/impedance and TBW measured using
deuterium dilution will be examined using regression
analysis. An equation for the estimation of TBW from
measures of height or length and impedance, specific for
young children with CP, will be developed [53]. Reliability
of measurements of impedance in this population will be
determined.
Habitual time spent sedentary
The time that children spend sedentary in their own free-
living environment will be measured using the ActiGraph
GT3M accelerometer (Shalimar, FL). The GT3M is a
small (3.8 × 3.7 × 1.8 cm), lightweight (27 g) triaxial accel-
erometer that detects accelerations of a magnitude and
frequency that correspond with human movement, filter-
ing out other forms of motion (e.g. vibration). Raw accel-
eration data is recorded in real time as counts per minute.
Output from the device can be used to indicate when the
wearer was active, as well as when they were sedentary.
Accelerometry is the most appropriate method for
measurement of sedentary behaviour in this study. Self-
report is inappropriate in this age-group as our pilot data
demonstrate that parental report correlates poorly with
criterion measures in the target population [65]. Pedome-
ters measure only steps and are therefore inappropriate
for use with children who do not walk, and doubly
labelled water, while considered the gold standard for the
measurement of physical activity, is prohibitively expen-
sive and will not provide data on patterns of activity.
Additionally, the ActiGraph has demonstrated cross-
validity with criterion measures of activity in populations,
age groups and activities relevant to the current study
including: hip worn ActiGraphs for walking people with
brain injury (r = 0.74) [66]; for measuring free play in
young children (r = 0.72) [67]; and wrist worn ActiGraphs
for measuring wheelchair activity in people with disabili-
ties (r = 0.66) [68].
Time spent sedentary vs time spent active While both
time spent active and sedentary behaviour have estab-
lished links with child health outcomes [36], our study
will focus on measurement of sedentary behaviour. Time
spent active will not be used as an outcome measure as
young children with CP move in a variety of ways includ-
ing walking, running, crawling, creeping, rolling, and bot-
tom-shuffling. In combination with disordered
movement kinematics and kinetics, these diverse modes
of movement make the relationship between counts per
minute and activity intensity for children with CP unpre-
dictable. As a consequence, identification of time spent in
moderate to vigorous physical activity (the intensity rec-
ommended for normal growth and development [36]) is
impossible to derive from accelerometer output in this
population. In contrast to accelerometer-based measure-
ment of activity, we can be confident that, providing a
child is wearing the monitor, if counts per minute are
zero, the child is sedentary.
Identification of cut points for sedentary behaviour 
There is a methodological challenge in choosing to mea-
sure sedentary behaviour: when counts per minute areBell et al. BMC Public Health 2010, 10:179
http://www.biomedcentral.com/1471-2458/10/179
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greater than zero it does not necessarily follow that the
child is active (e.g., very low but non-zero counts per
minute will be registered with regular weight-shift that
occurs with prolonged sitting). Therefore, in order to val-
idly determine when a child has been sedentary, a crite-
rion validity study will be conducted to determine cut-
points for differentiating between sedentary behaviour
and non-sedentary behaviour. The method used will be
based on that described by Welk et al [69]
Participants in the criterion validation study for the
Actigraph will be 100 children with CP participating in
the Queensland CP Child Study of Motor Function and
Brain Development, with a minimum of two children in
each of the 15 possible combinations of age (17 to 25
months, 36 ± 1 months and 60 ± 1 months) and GMFCS
level (I-V) in our sample. As part of their evaluation, chil-
dren in the Queensland CP Child: Brain and Motor
Development Study complete the Gross Motor Function
Measure 66 [47], a standardised motor assessment bat-
tery which takes between 40-60 min to complete and
requires the children to complete a range of motor tasks
(e.g., sitting, standing, rolling, crawling etc). During these
assessments, children will wear an Actigraph GT3M and
will be video taped. The video of the assessment will sub-
sequently be coded using BEST direct observation soft-
ware to provide a real-time criterion measure of when the
child was active and when they were sedentary. Active
behaviour is defined as either positional change where
the centre of gravity is moved (e.g., sit to stand, stand to
sit, bending down) or translocation of any description
(e.g., walking, crawling, rolling). Sedentary behaviour is
defined as the child being stationary with or without limb
or head movement. To derive unique sedentary cut-
points (count per minute) which maximize sensitivity and
specificity in each of the 15 cells, a receiver operator char-
acteristic curve analysis will be conducted. For this analy-
sis, counts per minute will serve as the independent
variable, with a (1, 0) indicator variable corresponding to
1 = sedentary (as determined from direct observation)
versus 0 = non-sedentary activity (again, as determined
from direct observation) serving as the dependent vari-
able.
Measurement of habitual time spent sedentary To
measure free-living sedentary behaviour at each of the
three planned data collection points, ActiGraphs will be
set for 15 second epochs and worn at the centre of the
child's back [70], for a period of 3 days, the minimum
required for a valid estimate of habitual activity in chil-
dren [70]. Children will be required to wear the Actigraph
during waking hours only and parents will be given
instructions for wear and logging wear-time. After 3 days,
the ActiGraph will be returned by courier for data extrac-
tion and analysis. Following return, output will be analy-
sed for periods of non-wear and the data converted to
mean counts per minute for the monitoring period. Anal-
ysis will be performed according to functional severity
(GMFCS) with mean counts per minute used to stratify
participants into high, medium and low levels of seden-
tary behaviour.
Dietary intake
Usual dietary intake will be determined using a three day
weighed food record [71]. Parents will be instructed to
weigh all food and fluids offered to the child before and
after consumption. Parents will also be instructed to
record information regarding the amount of food and flu-
ids lost due to spillage as well as the time taken (in min-
utes) for the child to consume each meal, snack or drink.
Food records will be reviewed by the Research Dietician
with the caregiver present to clarify any ambiguous infor-
mation. Food records will be analysed using the Food-
works™ dietary analysis software program (Xyris Software
(Australia) Pty Ltd). Mean energy intake will be expressed
as a percentage of age and gender specific recommenda-
tions [72].
Feeding ability
Oral motor and swallowing function will be assessed
using a number of measures obtained from a parent com-
pleted feeding questionnaire, direct observation during a
clinical feeding evaluation of a regular meal and from rat-
ings derived from the video taped clinical feeding evalua-
tion. Saliva control and drooling measures were derived
from parent report and clinician's rating during the clini-
cal feeding evaluation using a five point scale for severity
and four point scale for frequency described by Thomas-
Stonell and Greenberg [73]. A subset of clinical signs sug-
gestive of aspiration will be noted from parent report in
the feeding questionnaire and during the clinical feeding
evaluation [74]. Objective measurement of oral motor
function during feeding will be rated from the videotaped
clinical feeding evaluation using the Schedule for Oral
Motor Assessment (SOMA). The SOMA was normalised
on 127 young infants aged 8-24 months with 10% of the
population having CP. It has a positive predictive validity
of 90% and sensitivity greater than 85% to detect clinically
significant oral-motor dysfunction in infants and young
children. This assessment has also been used to evaluate
children of older ages. The SOMA has excellent levels of
inter-rater reliability (kappa > 0.75) and intra-rater reli-
ability (85%) [75-77]. Oral motor and swallowing func-
tion will also be formally rated using the Feeding and
Swallowing Competency Subtest (Part 2) of the Dys-
phagia Disorders Survey (DDS) - Pediatric [17,78]. The
DDS was developed as a screening tool to assess feeding
and swallowing function in children and adults with
developmental disability [3-78 years; mean 31.71 years]
with 5% of the population aged 3-17 years (n = 31). It has
more recently been used in a group of 166 children (2
years 1 month - 19 years 1 month; mean 9 years 4Bell et al. BMC Public Health 2010, 10:179
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months) with moderate to severe CP and intellectual dis-
ability [17,78]. Test validity and inter-item reliability were
determined from a sample of 626 people with develop-
mental disability. Inter-rater reliability was undertaken on
a sample of 21 participants by 6 speech pathologists and
achieved excellent reliability of 97% [17,78]. Inter-rater
reliability of direct ratings for the SOMA and DDS will be
compared for 10% of the participants in our study.
Participation
Participation will be determined using parent-report on
the domains of self-care, mobility and social functioning
using the scaled scores (rasch analysed) of the Pediatric
Evaluation of Disability Inventory (PEDI) [79]. The PEDI
is a generic standardised instrument of functional perfor-
mance in children with disabilities that has been found to
be both valid and reliable. It has been standardised on a
sample of 412 able bodied American children between
the ages of 0.5 and 7.5 years [79]. There are three inde-
pendent domains of the PEDI (participation in self-care,
mobility and social function) that are rated by parent
r e p o r t  a s  c a p a b l e  ( s c o r e  =  1 )  o r  i n c a p a b l e  t o  p e r f o r m
(score = 0). The PEDI has been found to be a valid and
reliable assessment of functional performance in children
with disabilities [79].
The mobility and self-care domain of the PEDI will be
completed by the caregiver to assess the child's participa-
tion in activities of daily living. On the first occasion the
PEDI will be administered as an interview (15-20 mins).
On subsequent occasions it will be provided as a ques-
tionnaire mailed to the family for completion prior to the
study visit, and will be checked by the researcher at the
study visit. The PEDI raw aggregate scores can be con-
verted into normative standard scores and scaled scores
using conversion tables provided in the manual [79].
Scaled scores provide an indication of the child's perfor-
mance along a continuum of item difficulty or complexity
in a particular domain. The range of possible scores (0-
100) represents increasing levels of function. In the pres-
ent study, all raw scores will be converted to scaled scores
(Rasch analysed) to compare the entire group (age range
18 months to five years) of all children across the self-care
domain for capability, without the difficulties of 'ceiling
and floor' effects due to age limitation in the normative
standard scores.
Quality of life
Parent perception of QOL will be assessed using the con-
dition specific tool CP QOL-child (CP QOL-Child) from
4 years of age [80]. The CP QOL-Child assesses aspects of
life that parents and children have identified as important
including physical wellbeing, social wellbeing, emotional
wellbeing, school, access to services, and acceptance by
others. The psychometric properties of the CP QOL -
Child are excellent with Cronbach's Alpha range from
0.74-0.92 for parent-proxy report [80]. Test re-test is ade-
quate, where ICC 0.76-0.89 and it is moderately corre-
lated with generic QOL and health (r = 0.30-0.51) [80]
Resource use and the direct costs of treatment
In order to determine the relationship between motor
prognosis and resource use, medical and allied health
resource use and the direct costs of treatment will be
monitored and compared to outcomes with adjustment
for confounders such as disease severity using cost and
consequences analysis [81].
Sample size calculations
240 children will be studied with three measurements
planned for each participant between 18 months and 5
years of age. F or hypothesis 1, a sample size of 45 per
group (GMFCS I-V, totalling 225 patients) will have 80%
power and 5% significance of detecting a between group
difference in height of 6 cm (assuming a standard devia-
tion of change of 10 cm) between 18 months and 5 years
of age, between functional groups and non-CP infants
[52]. To allow for attrition we will enrol 240 infants in
total.
Statistical considerations
Primary analysis will use the intention to treat principle,
using the Last Observation Carried Forward principle for
participants who withdraw before the end of the study
period. Differences between participants who complete
and withdraw will be assessed using t-tests for continu-
ous variables, after transformations of non-normally dis-
tributed variables, and Fisher's Exact Test for categorical
variables. Baseline characteristics of the GMFCS groups
will be compared similarly. Details for the statistical mod-
e l s  t h a t  w i l l  b e  u s e d  t o  a n a l y s e  d a t a  t o  a d d r e s s  e a c h
hypothesis are as described below.
H1
Outcome is attainment of GMFCS, a 5-level categorical
variable at 5 yrs. We will consider the explanatory vari-
ables of growth and nutritional status in separate models.
Individual Z-scores for height or predicted height from
knee height or upper arm length will be determined at 18,
36 and 5 yrs and modelled using mixed-effects models.
These models are used as they incorporate both fixed and
random variables in the analysis. We will model using a
random-intercept and slope for each participant. We will
test potential covariates (eg sex) and include them as
fixed effects if appropriate.
H2
Outcome is attainment of GMFCS at 5 years. Explanatory
variables are fat free mass and fat mass at 18, 36 and 5
years. We will investigate the association between explan-
atory and outcome variables using separate mixed-effects
models.Bell et al. BMC Public Health 2010, 10:179
http://www.biomedcentral.com/1471-2458/10/179
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H3a
Outcome variables are growth status and body composi-
tion. We will investigate the association with explanatory
variables of dietary intake and habitual physical activity at
3 years and 5 years. We will use mixed-effects models
with random intercept and slope for each participation,
with GMFCS as a fixed effect and with appropriate inter-
action terms.
H3b
Outcome variables are growth status, nutritional status
and body composition at 5 years of age. Explanatory vari-
ables are dietary intake and time spent sedentary at 18
months of age. We will investigate the ability of the
explanatory variables to predict the outcome variables
using mixed-effects models.
H4
Outcomes are health care utilization and direct medical
costs, participation (PEDI) at 3 and 5 years and QOL at 5
yrs. Explanatory variables are growth, body composition
and time spent sedentary at 18 months and 36 months.
We will investigate the association between explanatory
and outcome variables using mixed-effects models with a
random intercept and slope for each participant, and
f u n c t i o n a l  s e v e r i t y  a t  1 8  m o n t h s  i n c l u d e d  a s  a  f i x e d
effect.
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